Xeris Biopharma Holdings Inc (XERS) Profitability Comparisons, Net Margin, Gross Margin, Tax rate, Cash Flow Margin Comparisons - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Gross Margin
• EBITDA Margin
• Operating Margin
• Net Margin
• Pre-Tax Margin
• Effective Tax Rate
• Free Cash Flow Margin
• Cash Flow Margin
Xeris Biopharma Holdings Inc   (NASDAQ: XERS)

Xeris Biopharma Holdings Inc Profitability Comparisons

Select each Category to receive further Information



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

XERS Profitability Ratio

 Company Industry Sector S&P 500
Gross Profit Margin (Q2 MRQ) 86.41 % 70.91 % 65.43 % 46.06 %
Gross Margin (Q2 TTM) 86.58 % 71.73 % 66.39 % 46.3 %
Gross Profit Margin 5 Yr. Avg. 80.48 % 67.82 % 65.56 % 47.82 %
EBITDA Margin (Q2 MRQ) 4.28 % 22.25 % 19.59 % 20.7 %
EBITDA Margin (Q2 TTM) 5.2 % 25.28 % 20.86 % 19.16 %
EBITDA Margin 5 Yr. Avg. --82.78 % 47.09 % 31.57 % 22.37 %
Operating Margin (Q2 MRQ) 5.62 % 17.27 % 16.57 % 16.03 %
Operating Margin (Q2 TTM) 10.91 % 20.33 % 17.92 % 16.33 %
Operating Margin 5 Yr. Avg. --68.29 % 15.37 % 14.33 % 17.24 %
Pre-Tax Profit Margin (Q2 MRQ) 0 % 13.66 % 10.93 % 13.94 %
Pre-Tax Profit Margin (Q2 TTM) 1.66 % 16.7 % 12.86 % 13.09 %
Pre-Tax Profit Margin 5 Yr. Avg. - 12.99 % 10.37 % 12.42 %
Net Margin (Q2 MRQ) 0 % 10.09 % 8.14 % 11.41 %
Net Margin (Q2 TTM) 5.01 % 13.13 % 9.99 % 10.76 %
Net Margin 5 Yr. Avg. - 5.8 % 6.08 % 9.9 %



Business Segment Profit Margin
 
Gvoke
  Explore Gvoke Segment  -
Recorlev
  Explore Recorlev Segment  -
Keveyis
  Explore Keveyis Segment  -
Product
  Explore Product Segment  -
Royalty, contract and other revenue
  Explore Royalty, contract and other revenue Segment  -